HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mirang Kim Selected Research

Therapeutics

1/2022DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapy.
11/2020EZH2 as a Potential Target for NAFLD Therapy.
1/2020Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer.
12/2018Large-scale pharmacogenomics based drug discovery for ITGB3 dependent chemoresistance in mesenchymal lung cancer.
11/2018Bcl-2-dependent synthetic lethal interaction of the IDF-11774 with the V0 subunit C of vacuolar ATPase (ATP6V0C) in colorectal cancer.
1/2018Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mirang Kim Research Topics

Disease

18Stomach Neoplasms (Stomach Cancer)
05/2023 - 02/2008
15Neoplasms (Cancer)
01/2023 - 06/2011
4Lung Neoplasms (Lung Cancer)
01/2022 - 01/2018
4Carcinogenesis
12/2018 - 06/2011
2Metaplasia
12/2022 - 12/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Non-alcoholic Fatty Liver Disease
11/2020
1Neoplasm Metastasis (Metastasis)
01/2020
1Lymphoma (Lymphomas)
01/2020
1Ovarian Neoplasms (Ovarian Cancer)
01/2020
1Ectopic Pregnancy
01/2019
1Hemoperitoneum
01/2019
1Hemorrhage
01/2019
1Colorectal Neoplasms (Colorectal Cancer)
11/2018
1Lacerations
02/2018
1Wounds and Injuries (Trauma)
02/2018
1Alzheimer Disease (Alzheimer's Disease)
01/2017
1Parkinson Disease (Parkinson's Disease)
04/2015
1Hepatocellular Carcinoma (Hepatoma)
11/2005
1Breast Neoplasms (Breast Cancer)
04/2002

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
11/2018 - 06/2011
4MicroRNAs (MicroRNA)IBA
07/2018 - 06/2011
4Small Interfering RNA (siRNA)IBA
11/2015 - 08/2008
3hydrogen sulfite (bisulfite)IBA
12/2022 - 11/2015
3ChromatinIBA
01/2021 - 01/2017
3DNA (Deoxyribonucleic Acid)IBA
12/2018 - 03/2011
3Messenger RNA (mRNA)IBA
01/2017 - 04/2002
3Proteins (Proteins, Gene)FDA Link
01/2012 - 09/2008
3DecitabineFDA Link
06/2011 - 08/2008
2Anaplastic Lymphoma KinaseIBA
01/2022 - 01/2018
2Bortezomib (Velcade)FDA Link
03/2021 - 01/2020
2Histone Deacetylase InhibitorsIBA
01/2018 - 09/2008
2LuciferasesIBA
11/2015 - 04/2002
2trichostatin A (A 300)IBA
09/2008 - 08/2008
1TensinsIBA
05/2023
1Gastrointestinal Hormone Receptors (Gastrointestinal Hormone Receptor)IBA
12/2018
1Unithiol (DMPS)IBA
12/2018
1Hormones (Hormone)IBA
12/2018
1GastrinsIBA
12/2018
1IDF-11774IBA
11/2018
1Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA
11/2018
1Epithelial Cell Adhesion MoleculeIBA
07/2018
1Rose BengalIBA
02/2018
1Coloring Agents (Dyes)IBA
02/2018
1PanobinostatIBA
01/2018
1Untranslated RNA (Noncoding RNA)IBA
05/2016
15-hydroxymethylcytosineIBA
11/2015
1Dopamine (Intropin)FDA LinkGeneric
04/2015
1Pyruvate KinaseIBA
06/2012
1Matrix Metalloproteinases (MMPs)IBA
02/2012
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2012
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2012
1Leucine (L-Leucine)FDA Link
09/2008
1Transcription Factor 4IBA
08/2008
1EnzymesIBA
08/2008
1Protein Kinases (Protein Kinase)IBA
03/2008
1CollagenIBA
02/2008
1DiscoidinsIBA
02/2008
1AlbuminsIBA
11/2005
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
04/2002
1Initiator Codon (Start Codon)IBA
04/2002

Therapy/Procedure

6Therapeutics
01/2022 - 01/2018
1Cell Transplantation
01/2023
1Drug Therapy (Chemotherapy)
01/2020
1Precision Medicine
01/2020
1Surgical Instruments (Clip)
01/2019
1Sutures (Suture)
02/2018
1Gastrectomy
02/2012